Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexandra B. Kimball, M.D.


Identification of phenotypic subtypes of hidradenitis suppurativa through investigation of re-epithelialization and skin microbiota
Full Time, 07/08/13 - 07/07/14
Skin Cancer Incidence in Patients Presenting for Routine Dermatological Care
Full Time/Year Long, 08/15/12 - 06/01/13
Self-Perception of Facial Skin Aging in Men
Summer, 06/19/06 - 08/11/06
Epidemiology of acne vulgaris across five ethnicities
Full Time/Year Long, 07/01/06 - 06/30/07
Obesity and Age at Diagnosis Impact Quality of Life and Long-Term Outcomes in Psoriasis Patients
Summer, 06/26/12 - 08/10/12

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gibson RS, Porter ML, Kimball AB. Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant. Int J Womens Dermatol. 2021 Sep; 7(4):510-511. PMID: 34621972.
  2. Stevens JP, Mechanic O, Markson L, O'Donoghue A, Kimball AB. Telehealth Use by Age and Race at a Single Academic Medical Center During the COVID-19 Pandemic: Retrospective Cohort Study. J Med Internet Res. 2021 05 20; 23(5):e23905. PMID: 33974549.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Holcomb ZE, Porter ML, Kimball AB. A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs. Expert Opin Drug Saf. 2021 Oct; 20(10):1147-1161. PMID: 33910441.
    Citations:    Fields:    Translation:Humans
  4. Porter ML, Kimball AB. Quantifying Itch: Measurement on the Way to Management. Cutis. 2021 Apr; 107(4):167-168. PMID: 34096841.
    Citations:    Fields:    Translation:Humans
  5. Kimball AB, Guenther L, Kalia S, de Jong EMGJ, Lafferty KP, Chen DY, Langholff W, Shear NH. Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2021 03 01; 157(3):301-306. PMID: 33533924.
    Citations: 3     Fields:    Translation:Humans
  6. Taylor EM, Hamaguchi R, Kramer KM, Kimball AB, Orgill DP. Plastic Surgical Management of Hidradenitis Suppurativa. Plast Reconstr Surg. 2021 03 01; 147(3):479-491. PMID: 33620946.
    Citations:    Fields:    Translation:Humans
  7. Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2021 Jan 23. PMID: 33493574.
    Citations:    Fields:    
  8. Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S, Eichner S, Flores-Caldera I, Horne AW, Kimball AB, Laufer MR, Leyland N, Singh SS, Taylor HS, As-Sanie S. Impact of Endometriosis on Life-Course Potential: A Narrative Review. Int J Gen Med. 2021; 14:9-25. PMID: 33442286.
    Citations: 5     
  9. Mechanic OJ, Nguyen N, Kimball AB, Awtrey C. TeleConnect: digitally connecting physicians across the health care system. Am J Manag Care. 2021 01 01; 27(1):e4-e6. PMID: 33471462.
    Citations:    Fields:    Translation:Humans
  10. Golbari NM, van der Walt JM, Blauvelt A, Ryan C, van de Kerkhof P, Kimball AB. Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):417-421. PMID: 32978847.
    Citations:    Fields:    Translation:Humans
  11. Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak L, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. What causes hidradenitis suppurativa ?-15 years after. Exp Dermatol. 2020 12; 29(12):1154-1170. PMID: 33058306.
    Citations: 5     Fields:    
  12. Nagler AR, Shinkai K, Kimball AB. Burnout Among All Groups of Physicians-Mitigation Strategies for Dermatologists. JAMA Dermatol. 2020 10 01; 156(10):1049-1050. PMID: 32756892.
    Citations:    Fields:    Translation:Humans
  13. Flood KS, Porter ML, Kimball AB. A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinic. J Am Acad Dermatol. 2021 03; 84(3):e155-e160. PMID: 33010310.
    Citations:    Fields:    Translation:Humans
  14. Oblong JE, Bowman A, Rovito HA, Jarrold BB, Sherrill JD, Black MR, Nelson G, Kimball AB, Birch-Machin MA. Metabolic dysfunction in human skin: Restoration of mitochondrial integrity and metabolic output by nicotinamide (niacinamide) in primary dermal fibroblasts from older aged donors. Aging Cell. 2020 10; 19(10):e13248. PMID: 32990346.
    Citations: 2     Fields:    Translation:HumansCells
  15. Flood KS, Savage KT, Porter ML, Kimball AB. Treatment of psoriasis in pregnancy. Cutis. 2020 Aug; 106(2S):15-20. PMID: 33104095.
    Citations:    Fields:    Translation:Humans
  16. Prens EP, Lugo-Somolinos AM, Paller AS, Kerdel F, Duan Y, Teixeira HD, Longcore M, Kimball AB. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice. Am J Clin Dermatol. 2020 Aug; 21(4):579-590. PMID: 32077014.
    Citations: 4     Fields:    Translation:Humans
  17. Kimball AB. High placebo rates in clinical trials: Is the problem scoring systems or drug efficacy? J Am Acad Dermatol. 2020 12; 83(6):e431. PMID: 32682883.
    Citations:    Fields:    Translation:Humans
  18. Holcomb ZE, Santillan MR, Morss-Walton PC, Salian P, Her MJ, Giannotti NM, Kimball AB, Porter ML. Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy. J Am Acad Dermatol. 2020 Oct; 83(4):1215-1218. PMID: 32622141.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  19. Kumar S, Flood K, Golbari NM, Charrow AP, Porter ML, Kimball AB. Psoriasis: Knowledge, attitudes and perceptions among primary care providers. J Am Acad Dermatol. 2021 May; 84(5):1421-1423. PMID: 32526322.
    Citations:    Fields:    Translation:Humans
  20. Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 03 12; 6(1):18. PMID: 32165620.
    Citations: 22     Fields:    Translation:Humans
  21. Rosales Santillan M, Morss PC, Porter ML, Kimball AB. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020 06; 20(6):621-633. PMID: 32077334.
    Citations: 1     Fields:    Translation:Humans
  22. Savage KT, Brant EG, Rosales Santillan M, Morss PC, Salian P, Flood KS, Porter ML, Kimball AB. Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa. Int J Womens Dermatol. 2020 Jun; 6(3):159-163. PMID: 32637536.
    Citations: 1     
  23. Savage KT, Santillan MR, Flood KS, Charrow A, Porter ML, Kimball AB. Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Rep. 2020 Feb; 6(2):99-102. PMID: 31993474.
    Citations: 3     
  24. Kleyn CE, Talbot PS, Mehta NN, Sampogna F, Bundy C, Ashcroft DM, Kimball AB, van de Kerkhof PCM, Griffiths CEM, Valenzuela F, van der Walt JM, Aberra T, Puig L. Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk. Acta Derm Venereol. 2020 01 07; 100(1):adv00020. PMID: 31742649.
    Citations: 4     Fields:    Translation:Humans
  25. Reich K, Griffiths CEM, Gordon KB, Papp KA, Song M, Randazzo B, Li S, Shen YK, Han C, Kimball AB, Armstrong AW, Foley P, Blauvelt A. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials. J Am Acad Dermatol. 2020 Apr; 82(4):936-945. PMID: 31809827.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  26. Charrow A, Savage KT, Flood K, Kimball AB. Hidradenitis suppurativa for the dermatologic hospitalist. Cutis. 2019 Nov; 104(5):276-280. PMID: 31886786.
    Citations:    Fields:    Translation:Humans
  27. Sadeghpour M, Sung SM, Jacobe H, Kimball AB. Career satisfaction of leaders in academic dermatology: Results from a national survey. Int J Womens Dermatol. 2020 Jan; 6(1):25-29. PMID: 32025557.
    Citations: 1     
  28. Flood KS, Porter ML, Kimball AB. Biologic Treatment for Hidradenitis Suppurativa. Am J Clin Dermatol. 2019 Oct; 20(5):625-638. PMID: 31140067.
    Citations: 3     Fields:    Translation:Humans
  29. Yosipovitch G, Dong Y, Burge R, Zhu B, Shrom D, Kimball AB. Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis. Acta Derm Venereol. 2019 Oct 01; 99(11):1031-1032. PMID: 31290556.
    Citations: 1     Fields:    Translation:Humans
  30. Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019 09 30; 9(9):e030579. PMID: 31575575.
    Citations: 3     Fields:    Translation:Humans
  31. Strober B, Ryan C, van de Kerkhof P, van der Walt J, Kimball AB, Barker J, Blauvelt A. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council. J Am Acad Dermatol. 2020 Jan; 82(1):117-122. PMID: 31425723.
    Citations: 8     Fields:    Translation:Humans
  32. Savage KT, Flood KS, Porter ML, Kimball AB. TNF-a inhibitors in the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2019; 10:2040622319851640. PMID: 31191873.
    Citations: 5     
  33. Popatia S, Flood KS, Golbari NM, Patel PV, Olbricht SM, Kimball AB, Porter ML. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review. J Am Acad Dermatol. 2019 Dec; 81(6):1308-1318. PMID: 31103568.
    Citations: 2     Fields:    Translation:Humans
  34. Flood KS, Houston NA, Savage KT, Kimball AB. Genetic basis for skin youthfulness. Clin Dermatol. 2019 Jul - Aug; 37(4):312-319. PMID: 31345318.
    Citations: 2     Fields:    Translation:HumansCells
  35. Flood KS, Porter ML, Kimball AB. Use of biologics in pregnancy: limitations stemming from clinical trials and registry experience. J Eur Acad Dermatol Venereol. 2019 08; 33(8):e276-e277. PMID: 30848856.
    Citations:    Fields:    Translation:Humans
  36. Savage KT, Flood KS, Popatia S, Golbari NM, Salian P, Kimball AB, Porter ML. Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment". J Am Acad Dermatol. 2019 07; 81(1):e19-e20. PMID: 30914340.
    Citations:    Fields:    
  37. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019 Jul; 81(1):91-101. PMID: 30872149.
    Citations: 19     Fields:    Translation:Humans
  38. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019 Jul; 81(1):76-90. PMID: 30872156.
    Citations: 31     Fields:    Translation:Humans
  39. Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. Clinical Goals and Barriers to Effective Psoriasis Care. Dermatol Ther (Heidelb). 2019 Mar; 9(1):5-18. PMID: 30578464.
    Citations: 11     
  40. Kimball AB, Tzellos T, Calimlim BM, Teixeira HD, Geng Z, Okun MM. Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II. Acta Derm Venereol. 2018 Nov 05; 98(10):932-937. PMID: 30085324.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  41. Porter ML, Kimball AB. Predictions, Surprises, and the Future of the Dermatology Workforce. JAMA Dermatol. 2018 11 01; 154(11):1253-1255. PMID: 30193360.
    Citations:    Fields:    Translation:Humans
  42. Kimball AB, Sundaram M, Gauthier G, Guérin A, Pivneva I, Singh R, Ganguli A. The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis. Dermatol Ther (Heidelb). 2018 Dec; 8(4):557-569. PMID: 30306395.
    Citations: 5     
  43. Porter ML, Golbari NM, Lockwood SJ, Kimball AB. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa. Semin Cutan Med Surg. 2018 Sep; 37(3):182-189. PMID: 30215636.
    Citations: 6     Fields:    Translation:Humans
  44. Golbari NM, Porter ML, Kimball AB. Online communications among hidradenitis suppurativa patients reflect community needs. J Am Acad Dermatol. 2019 06; 80(6):1760-1762. PMID: 30165167.
    Citations: 1     Fields:    Translation:Humans
  45. Golbari NM, Porter ML, Kimball AB. Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television Advertisements. J Drugs Dermatol. 2018 Aug 01; 17(8):886-887. PMID: 30124728.
    Citations: 1     Fields:    Translation:Humans
  46. Griffiths CEM, Papp KA, Kimball AB, Randazzo B, Song M, Li S, Shen YK, Blauvelt A. Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years. J Drugs Dermatol. 2018 Aug 01; 17(8):826-832. PMID: 30124721.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  47. Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis Rheumatol. 2018 09; 70(9):1399-1407. PMID: 29623679.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  48. Golbari NM, Porter ML, Kimball AB. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2019 Jan; 80(1):114-119. PMID: 30003993.
    Citations: 7     Fields:    Translation:Humans
  49. Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A. Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials. J Am Acad Dermatol. 2018 Dec; 79(6):1141-1143. PMID: 29787843.
    Citations: 6     Fields:    Translation:Humans
  50. Zachariae C, Gordon K, Kimball AB, Lebwohl M, Blauvelt A, Leonardi C, Braun D, McKean-Matthews M, Burge R, Cameron G. Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis. J Am Acad Dermatol. 2018 Aug; 79(2):294-301.e6. PMID: 29653208.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  51. Golbari NM, Lee Porter M, Kimball AB. Response to: Remission of hidradenitis suppurativa after bariatric surgery. JAAD Case Rep. 2018 Apr; 4(3):278-279. PMID: 29687072.
  52. Golbari NM, Porter ML, Kimball AB. Current guidelines for psoriasis treatment: a work in progress. Cutis. 2018 Mar; 101(3S):10-12. PMID: 29718028.
    Citations: 7     Fields:    Translation:Humans
  53. Kimball AB, Sundaram M, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A, Ganguli A. Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis. J Drugs Dermatol. 2018 Feb 01; 17(2):180-186. PMID: 29462226.
    Citations: 1     Fields:    Translation:Humans
  54. Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Burge R, Lin CY, Yosipovitch G. Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension. Acta Derm Venereol. 2018 Jan 12; 98(1):98-102. PMID: 28929168.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  55. Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD. Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA). Exp Dermatol. 2018 01; 27(1):104-112. PMID: 28898476.
    Citations: 2     Fields:    Translation:HumansCells
  56. Kimball AB, Alora-Palli MB, Tamura M, Mullins LA, Soh C, Binder RL, Houston NA, Conley ED, Tung JY, Annunziata NE, Bascom CC, Isfort RJ, Jarrold BB, Kainkaryam R, Rocchetta HL, Swift DD, Tiesman JP, Toyama K, Xu J, Yan X, Osborne R. Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age. J Am Acad Dermatol. 2018 Jan; 78(1):29-39.e7. PMID: 29146147.
    Citations: 10     Fields:    Translation:Humans
  57. Lockwood SJ, Prens LM, Kimball AB. Adverse Reactions to Biologics in Psoriasis. Curr Probl Dermatol. 2018; 53:1-14. PMID: 29131033.
    Citations: 6     Fields:    Translation:Humans
  58. Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Am Acad Dermatol. 2018 Jan; 78(1):70-80. PMID: 29102053.
    Citations: 15     Fields:    Translation:Humans
  59. Feldman SR, Green L, Kimball AB, Siu K, Zhao Y, Herrera V, Nyirady J, Alexis AF. Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis. J Dermatolog Treat. 2017 Dec; 28(8):716-721. PMID: 28737440.
    Citations: 6     Fields:    Translation:Humans
  60. Palli MA, McTavish H, Kimball A, Horn TD. Immunotherapy of Recurrent Herpes Labialis With Squaric Acid. JAMA Dermatol. 2017 08 01; 153(8):828-829. PMID: 28538997.
    Citations: 2     Fields:    Translation:Humans
  61. Hartman RI, Kimball AB. Psoriasis and latitude: Analytic approaches and future data needs. J Am Acad Dermatol. 2017 08; 77(2):e59. PMID: 28711108.
    Citations:    Fields:    Translation:Humans
  62. Kimball AB, Sundaram M, Banderas B, Foley C, Shields AL. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa. J Dermatolog Treat. 2018 Mar; 29(2):152-164. PMID: 28608738.
    Citations: 7     Fields:    Translation:Humans
  63. Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, Gelfand JM, Gottlieb AB, Kimball AB, Lebwohl M, Mehta NN, Paller AS, Schwimmer JB, Styne DM, Van Voorhees AS, Tom WL, Eichenfield LF. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017 07 01; 153(7):698-704. PMID: 28514463.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  64. Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Thaçi D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Lancet. 2017 07 15; 390(10091):276-288. PMID: 28596043.
    Citations: 87     Fields:    Translation:HumansCTClinical Trials
  65. Porter ML, Kimball AB. Comorbidities of hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):55-57. PMID: 28538744.
    Citations: 5     Fields:    Translation:Humans
  66. Shahwan KT, Kimball AB. Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis. J Am Acad Dermatol. 2017 Jun; 76(6):1198-1200.e1. PMID: 28522048.